​

Monte Rosa Therapeutics (GLUE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Monte Rosa Therapeutics Revenue Highlights

Latest Revenue (Y)

$75.62M

Latest Revenue (Q)

$23.19M

Monte Rosa Therapeutics Revenue by Period

Monte Rosa Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$75.62M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Monte Rosa Therapeutics generated $75.62M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Monte Rosa Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$23.19M-72.69%
2025-03-31$84.93M40.04%
2024-12-31$60.65M558.06%
2024-09-30$9.22M96.29%
2024-06-30$4.70M341.26%
2024-03-31$1.06M-87.84%
2023-12-31$8.75M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Monte Rosa Therapeutics generated $23.19M in revenue during Q2 2025, up -72.69% compared to the previous quarter, and up 2179.89% compared to the same period a year ago.

Monte Rosa Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$263.40M$41.90M
DNAGinkgo Bioworks$227.04M$49.60M
VALNValneva SE$153.70M$32.75M
DAWNDay One Biopharmaceuticals$131.16M$39.80M
GERNGeron$76.50M$47.23M
GLUEMonte Rosa Therapeutics$75.62M$23.19M
VIRVir Bio$74.20M$240.00K
TBPHTheravance Biopharma$64.38M$19.99M
MGTXMeiraGTx$33.28M$3.69M
REPLReplimune Group--
AVBPArriVent BioPharma--

GLUE Revenue FAQ

What is Monte Rosa Therapeutics’s yearly revenue?

Monte Rosa Therapeutics's yearly revenue for 2024 was $75.62M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. GLUE's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Monte Rosa Therapeutics’s quarterly revenue?

Monte Rosa Therapeutics's quarterly revenue for Q2 2025 was $23.19M, a -72.69% decrease from the previous quarter (Q1 2025), and a 394.01% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $84.93M, a 40.04% increase from the previous quarter (Q4 2024), and a 7882.05% increase year-over-year (Q1 2024). GLUE's quarterly revenue for Q4 2024 was $60.65M, a 558.06% increase from the previous quarter (Q3 2024), and a 592.95% increase year-over-year (Q4 2023).

What is Monte Rosa Therapeutics’s revenue growth rate?

Monte Rosa Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.